doi: 10.1159/000506879CrossRefGoogle ScholarPubMed Chanson, P., Arnoux, A., Mavromati, M., Brailly-Tabard, S., Massart, C., Young, & J., for the VARIETE Investigators (2016)
By qualifying patients for Zofran before starting GLP-1 medications, we aim to enhance our patients' comfort and adherence to their weight loss plans
Other studies have documented cognitive improvements from ALCAR supplementation in those with vascular dementia [25], those who recently suffered a stroke [26], and those with hepatic encephalopathy [27,28]
Neurology 50 , 18421846 (1998)
From private members clubs to exclusive medical practices, microdosing GLP-1 medications has emerged as the latest development in precision medicine, capturing attention across international media and prestigious medical journals alike
Reference Safwan M et al